Liebl B, Anhäupl T, Haen E, Remien J
Walther-Straub-Institut für Pharmakologie und Toxikologie, München, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Nov;338(5):523-8. doi: 10.1007/BF00179324.
The effect of the disulfide reducing agent dithiothreitol (DTT) and other thiols on binding of the beta-adrenoceptor antagonist (-)-125iodocyanopindolol (125ICYP) to human mononuclear leucocytes (MNL) was investigated. Saturation experiments and dissociation kinetics revealed two classes of specific 125ICYP binding sites, one of high and the other of low affinity, respectively. In intact MNL DTT caused a decrease in specific binding. This was due almost selectively to a decrease in the affinity of high affinity binding sites, which decreased gradually in a concentration-dependent manner to the affinity of low affinity binding sites. In MNL membranes DTT decreased not only the affinity but also the number of high affinity binding sites. The DTT effect was completely reversible by simple reoxidation on air. The structural isomers (+/-)-DTT. (-)-DTT and dithioerythritol revealed identical effects on specific binding, whereas the monothiols mercaptoethanol and alpha-monothioglycerol, having a lower redox potential, were considerably less effective. In the same concentration range that influenced specific binding. DTT stimulated intracellular cAMP production. These results suggest functionally important disulfide bridges which regulate the affinity of beta-adrenoceptor binding sites in human MNL. They stabilize the receptor in a high affinity state; their reduction causes the conversion of the high affinity state into a low affinity state in a process associated with stimulation of adenylate cyclase. Available evidence indicates that a similar transformation is made by beta-adrenoceptor agonists. Consequently low affinity 125ICYP binding sites preexistent in untreated cells could represent a reduced receptor state resulting from agonist-receptor interaction in vivo.
研究了二硫键还原剂二硫苏糖醇(DTT)和其他硫醇对β-肾上腺素能受体拮抗剂(-)-125碘氰吲哚洛尔(125ICYP)与人单核白细胞(MNL)结合的影响。饱和实验和解离动力学分别揭示了两类特异性125ICYP结合位点,一类具有高亲和力,另一类具有低亲和力。在完整的MNL中,DTT导致特异性结合减少。这几乎完全是由于高亲和力结合位点的亲和力降低,其以浓度依赖性方式逐渐降低至低亲和力结合位点的亲和力。在MNL膜中,DTT不仅降低了亲和力,还减少了高亲和力结合位点的数量。通过在空气中简单再氧化,DTT的作用完全可逆。结构异构体(±)-DTT、(-)-DTT和二硫赤藓糖醇对特异性结合显示出相同的作用,而氧化还原电位较低的单硫醇巯基乙醇和α-单硫甘油的作用则明显较弱。在影响特异性结合的相同浓度范围内,DTT刺激细胞内cAMP的产生。这些结果表明,在人MNL中,具有功能重要性的二硫键调节β-肾上腺素能受体结合位点的亲和力。它们将受体稳定在高亲和力状态;其还原导致高亲和力状态在与腺苷酸环化酶刺激相关的过程中转化为低亲和力状态。现有证据表明,β-肾上腺素能受体激动剂也会产生类似的转变。因此,未处理细胞中预先存在的低亲和力125ICYP结合位点可能代表体内激动剂-受体相互作用导致的受体还原状态。